A discrete choice experiment investigating preferences for funding drugs used to treat orphan diseases (eBook, 2010) [WorldCat.org]
skip to content
A discrete choice experiment investigating preferences for funding drugs used to treat orphan diseases Preview this item
ClosePreview this item
Checking...

A discrete choice experiment investigating preferences for funding drugs used to treat orphan diseases

Author: Emmanouil Mentzakis; Jeremiah E Hurley; Patricia Stefanowska; McMaster University. Centre for Health Economics and Policy Analysis.
Publisher: Hamilton, Ont. : Centre for Health Economics and Policy Analysis, McMaster University, 2010.
Series: CHEPA working paper series (Online), #10-01.
Edition/Format:   eBook : Document : EnglishView all editions and formats
Summary:
Policy debate about funding criteria for drugs used to treat rare, orphan diseases is gaining prominence. This study presents evidence from a discrete choice experiment investigating the preferences of the public regarding public funding for drugs used to treat rare diseases and common diseases using a convenient sample of university students. We find that: other things equal, the respondents do not prefer to have  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
Technical Report
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Emmanouil Mentzakis; Jeremiah E Hurley; Patricia Stefanowska; McMaster University. Centre for Health Economics and Policy Analysis.
OCLC Number: 541652284
Notes: Publisher's Web site: http://www.chepa.org.
Description: 1 online resource.
Series Title: CHEPA working paper series (Online), #10-01.
Responsibility: Emmanouil Mentzakis, Patricia Stefanowska, and Jeremiah Hurley.
More information:

Abstract:

Policy debate about funding criteria for drugs used to treat rare, orphan diseases is gaining prominence. This study presents evidence from a discrete choice experiment investigating the preferences of the public regarding public funding for drugs used to treat rare diseases and common diseases using a convenient sample of university students. We find that: other things equal, the respondents do not prefer to have the government spend more for drugs used to treat rare diseases; that respondents are not willing to pay more per life year gained for a rare disease than a common disease; and that the public weighs relevant attributes of the coverage decisions (e.g., costs, disease severity, treatment effectiveness) similarly for both rare and common diseases. The results confirm the importance of severity and treatment effectiveness in preferences for public funding. Though the first study of its kind, the results send a cautionary message regarding the special treatment of orphan drugs in coverage decision making.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.